SEC 13F Intelligence

Deep Track Capital, LP / BSFA

Deep Track Capital, LP’s Ani Pharmaceuticals Inc Position

Does Deep Track Capital, LP own Ani Pharmaceuticals Inc (BSFA)? Yes600.0K shares worth $46M (+0.75% of its 13F portfolio) as of Q1 2026, up from 477.7K shares the prior filed quarter.

Position Value
$46M
Q1 2026
Shares
600.0K
% of Portfolio
+0.75%
Quarters Held
12
currently held

Position History BSFA

Reported value by quarter
Q2 ’23: $28MQ2 ’23Q3 ’23: $23MQ4 ’23: $33MQ4 ’23Q1 ’24: $57MQ2 ’24: $30MQ2 ’24Q3 ’24: $30MQ4 ’24: $36MQ4 ’24Q1 ’25: $47MQ2 ’25: $46MQ2 ’25Q3 ’25: $41MQ4 ’25: $38MQ4 ’25Q1 ’26: $46Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026600.0K$46M+0.75%
Q4 2025477.7K$38M+0.67%
Q3 2025450.0K$41M+1.15%
Q2 2025700.0K$46M+1.46%
Q1 2025700.0K$47M+1.52%
Q4 2024649.0K$36M+1.34%
Q3 2024504.8K$30M+0.96%
Q2 2024466.1K$30M+0.89%
Q1 2024822.0K$57M+1.63%
Q4 2023600.0K$33M+1.10%
Q3 2023400.0K$23M+0.90%
Q2 2023514.0K$28M+1.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deep Track Capital, LP’s full portfolio or all institutional holders of BSFA.